Bloomberg Law
Nov. 19, 2020, 2:54 PM

Moderna Vaccine Production Is Gearing Up, Partner Lonza Says (2)

Naomi Kresge
Naomi Kresge
Bloomberg News

Lonza Group AG made its first commercial batch of the main ingredient in Moderna Inc.’s Covid-19 vaccine candidate in the U.S. last week and plans to start European production by the end of the month, Chairman Albert Baehny said.

The company is ramping up and fine-tuning its production lines, a process that may stretch into next year.

“We have access to the raw materials; we have access to the people,” Baehny said in an interview. The main challenge is “to optimize as much as possible.”

Lonza’s effort is key to ensuring a smooth rollout of Moderna’s vaccine, should the ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.